tiprankstipranks
Trending News
More News >
Cell Source (CLCS)
:CLCS
US Market

Cell Source (CLCS) Financial Statements

Compare
11 Followers

Cell Source Financial Overview

Cell Source's market cap is currently $12.82M. The company's EPS TTM is $-0.161; its P/E ratio is ―; Cell Source is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -4.33M$ -4.17M$ -4.02M$ -3.64M$ -3.81M
EBITDA$ -4.27M$ -4.17M$ -4.02M$ -3.51M$ -4.03M
Net Income$ -5.32M$ -5.17M$ -5.47M$ -4.56M$ -4.47M
Balance Sheet
Cash & Short-Term Investments$ 22.20K$ 222.66K$ 93.09K$ 245.12K$ 27.91K
Total Assets$ 195.17K$ 409.85K$ 313.77K$ 452.34K$ 114.78K
Total Debt$ 9.25M$ 7.90M$ 6.47M$ 4.81M$ 2.60M
Net Debt$ 9.23M$ 7.68M$ 6.38M$ 4.56M$ 2.57M
Total Liabilities$ 15.81M$ 13.04M$ 10.14M$ 8.40M$ 5.86M
Stockholders' Equity$ -15.61M$ -12.63M$ -9.83M$ -7.95M$ -5.74M
Cash Flow
Free Cash Flow$ -2.35M$ -3.14M$ -3.38M$ -2.77M$ -2.59M
Operating Cash Flow$ -2.35M$ -3.14M$ -3.38M$ -2.77M$ -2.59M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 2.15M$ 3.27M$ 3.23M$ 2.99M$ 2.60M
Currency in USD

Cell Source Earnings and Revenue History

Cell Source Debt to Assets

Cell Source Cash Flow

Cell Source Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis